We are live on ! Find out more
MP

Mangrove Partners Portfolio holdings

AUM $1.24B
1-Year Est. Return 41.74%
This Fund
S&P 500
This Quarter Est. Return
+24.95%
1 Year Est. Return
+41.74%
3 Year Est. Return
+169.22%
5 Year Est. Return
+150.23%
10 Year Est. Return
+417.9%
AUM
$1.44B
AUM Growth
-$42.2M
Cap. Flow
-$133M
Cap. Flow %
-9.26%
Top 10 Hldgs %
29.23%
Holding
202
New
26
Increased
19
Reduced
11
Closed
39

Top Buys

Rank Stock Value
1
TEVA icon
Teva Pharmaceuticals
TEVA
+$34.8M
2
X
US Steel
X
+$34.6M
3
AGR
Avangrid, Inc.
AGR
+$32.7M
4
WS icon
Worthington Steel
WS
+$26.7M
5
CTLT
CATALENT, INC.
CTLT
+$25M

Top Sells

Rank Stock Value
1
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
+$64.7M
2
IJR icon
iShares Core S&P Small-Cap ETF
IJR
+$62.7M
3
WFRD icon
Weatherford International
WFRD
+$56.8M
4
DELL icon
Dell
DELL
+$37.5M
5
SPLK
Splunk Inc
SPLK
+$32M

Sector Composition

Rank Sector Weight
1 Healthcare 12.86%
2 Consumer Discretionary 12.47%
3 Financials 11.09%
4 Industrials 7.54%
5 Communication Services 6.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ATEK.WS
76
DELISTED
Athena Technology Acquisition Corp. II Redeemable Warrants
ATEK.WS
$5.42M 0.38%
489,800
– –
GBBKW
77
DELISTED
Global Blockchain Acquisition Corp. Warrant
GBBKW
$5.39M 0.37%
500,000
– –
ACBAW
78
DELISTED
Ace Global Business Acquisition Ltd Warrant
ACBAW
$5.34M 0.37%
442,126
– –
BLEUW
79
DELISTED
bleuacacia ltd Warrants
BLEUW
$5.33M 0.37%
500,000
– –
PEGRW
80
DELISTED
Project Energy Reimagined Acquisition Corp. Warrant
PEGRW
$5.26M 0.37%
476,751
-23,249
-5% -$963
KVACW icon
81
Keen Vision Acquisition Corp Warrant
KVACW
$296K
$5.22M 0.36%
500,000
– –
CNDA
82
DELISTED
Concord Acquisition Corp II
CNDA
$4.73M 0.33%
450,000
– –
SBXC
83
DELISTED
SilverBox Corp III
SBXC
$4.71M 0.33%
449,798
-102
-0% -$1.07K
QDROW
84
DELISTED
Quadro Acquisition One Corp. Warrant
QDROW
$4.71M 0.33%
429,052
-3,000
-0.7% -$138
ESHA
85
DELISTED
ESH Acquisition Corp
ESHA
$4.66M 0.32%
450,000
– –
PLTNW
86
DELISTED
Plutonian Acquisition Corp. Warrant
PLTNW
$4.25M 0.3%
395,752
– –
GDST
87
DELISTED
Goldenstone Acquisition Limited Common Stock
GDST
$3.36M 0.23%
305,135
+138,270
+83% +$1.51M
DSAQ
88
DELISTED
Direct Selling Acquisition Corp.
DSAQ
$3.28M 0.23%
296,936
– –
QETA icon
89
Quetta Acquisition Corp
QETA
$3.02M 0.21%
296,352
– –
NPAB
90
DELISTED
New Providence Acquisition Corp. II Class A Common Stock
NPAB
$2.96M 0.21%
+274,388
New +$2.95M
TPB icon
91
Turning Point Brands
TPB
$1.48B
$2.91M 0.2%
99,259
– –
FORL
92
DELISTED
Four Leaf Acquisition Corp
FORL
$2.82M 0.2%
263,081
– –
PRLH
93
DELISTED
Pearl Holdings Acquisition Corp Class A Ordinary Shares
PRLH
$2.69M 0.19%
249,158
– –
AOGO
94
DELISTED
Arogo Capital Acquisition Corp. Class A Common Stock
AOGO
$2.34M 0.16%
217,523
– –
GHIX
95
DELISTED
Gores Holdings IX, Inc. Class A Common Stock
GHIX
$2.33M 0.16%
220,861
+7,379
+3% +$78K
OSRHW
96
OSR Health Warrant
OSRHW
$304K
$2.18M 0.15%
204,072
– –
HCVI
97
DELISTED
Hennessy Capital Investment Corp. VI Class A Common Stock
HCVI
$2.16M 0.15%
+207,500
New +$2.16M
OAKUW
98
DELISTED
Oak Woods Acquisition Corp Warrant
OAKUW
$1.92M 0.13%
178,681
– –
OPP
99
RiverNorth/DoubleLine Strategic Opportunity Fund
OPP
$189M
$1.84M 0.13%
215,899
+31,555
+17% +$261K
BLFY
100
DELISTED
Blue Foundry Bancorp
BLFY
$1.81M 0.13%
193,846
– –
2 3
4
5 6

Similar funds

GX
Greylock XIV Menlo Park, California $1.24B AUM
HCA
Harbor Capital Advisors Chicago, Illinois $1.23B AUM 30.56% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
FLII
First Long Island Investors Jericho, New York $1.23B AUM 14.42% 1-Year Est. Return
CCA
Clearwater Capital Advisors Hoffman Estates, Illinois $1.24B AUM 15.23% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
HTHT
Hemenway Trust Hemenway Trust Salem, New Hampshire $1.24B AUM 16.47% 1-Year Est. Return
BCP
BlackBarn Capital Partners New York $1.24B AUM 55.98% 1-Year Est. Return

Mangrove Partners's Q1 2024 Portfolio in Review

As of Q1 2024, Mangrove Partners held 202 positions worth $1.44B, down 2.8% from $1.48B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Mangrove Partners withdrew a net $133M in Q1 2024, closing 39 positions and reducing 11 holdings. Its most notable exit was Mirati Therapeutics, Inc. Common Stock, an estimated $64.7M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 13% of assets, up from 8.6% a quarter earlier, followed by Consumer Discretionary and Financials.

Against the trend, Mangrove Partners opened a new position in Teva Pharmaceuticals worth $39M.

  • Mangrove Partners's largest Q1 2024 buy was Teva Pharmaceuticals: 2,762,154 shares worth $39M.
  • Mangrove Partners added most to US Steel in Q1 2024, an estimated $34.6M increase.
  • Mangrove Partners's biggest Q1 2024 reduction was iShares Core S&P Small-Cap ETF, cutting an estimated $62.7M.
  • Mangrove Partners fully exited Mirati Therapeutics, Inc. Common Stock in Q1 2024, selling an estimated $64.7M.
  • Mangrove Partners's ten largest holdings make up 29% of its $1.44B portfolio in Q1 2024.
  • Mangrove Partners opened 26 new positions and closed 39 in Q1 2024.
  • Mangrove Partners's portfolio value fell 2.8% quarter-over-quarter to $1.44B.

Based on Mangrove Partners's 13F filing for Q1 2024, filed 15 May 2024.